HNF4A and metabolic dysfunction-associated steatotic liver disease: In addition, an integrative analysis of NAFLD signatures in human and genetically modified mouse models[43] demonstrated that HNF4A as a transcription factor plays an important role in regulating the expression of the genes involved in the progression of NAFLD to hepatocellular carcinoma.